Report error Found 30 Enz. Inhib. hit(s) with all data for entry = 13594
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent
Wuhan Humanwell Innovative Drug Research And Development Center
US Patent














